Evidence map›Paper›PMID 34771551›Full record

ArticleCancers2021

Cancer Tissue Classification Using Supervised Machine Learning Applied to MALDI Mass Spectrometry Imaging.

Paul Mittal, Mark R Condina, Manuela Klingler-Hoffmann, Gurjeet Kaur, Martin K Oehler, Oliver M Sieber, Michelle Palmieri, Stefan Kommoss, Sara Brucker, Mark D McDonnell and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Mass Spectrometry Imaging for Spatial Ingredient Classification in Plant-Based Food.Journal of the American Society for Mass Spectrometry · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Paul MittalFuture Industries Institute, University of South Australia, Mawson Lakes 5095, Australia.
Mark R CondinaFuture Industries Institute, University of South Australia, Mawson Lakes 5095, Australia.
Manuela Klingler-HoffmannFuture Industries Institute, University of South Australia, Mawson Lakes 5095, Australia.
Gurjeet KaurInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden Penang 11800, Pulau Pinang, Malaysia.ORCID 0000-0002-6232-5703
Martin K OehlerDepartment of Gynaecological Oncology, Royal Adelaide Hospital, North Terrace, Adelaide 5000, Australia.
Oliver M SieberPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville 3052, Australia.ORCID 0000-0001-9480-0786
Michelle PalmieriPersonalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville 3052, Australia.
Stefan KommossDepartment of Women's Health, Tübingen University Hospital, Calwerstr. 7, 72076 Tübingen, Germany.
Sara BruckerDepartment of Women's Health, Tübingen University Hospital, Calwerstr. 7, 72076 Tübingen, Germany.ORCID 0000-0001-5162-1542
Mark D McDonnellComputational Learning Systems Laboratory, UniSA STEM, University of South Australia, Mawson Lakes 5095, Australia.
Peter HoffmannFuture Industries Institute, University of South Australia, Mawson Lakes 5095, Australia.
University of South Australia · AUThe University of Melbourne · AUUniversity Children's Hospital Tübingen · DERoyal Adelaide Hospital · AUUniversiti Sains Malaysia · MY

Funding

Bioplatforms Australia, NHMRC Senior Research Fellowship GNT1136119
6 · The paper itself

Abstract

Matrix assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) can determine the spatial distribution of analytes such as protein distributions in a tissue section according to their mass-to-charge ratio. Here, we explored the clinical potential of machine learning (ML) applied to MALDI MSI data for cancer diagnostic classification using tissue microarrays (TMAs) on 302 colorectal (CRC) and 257 endometrial cancer (EC)) patients. ML based on deep neural networks discriminated colorectal tumour from normal tissue with an overall accuracy of 98% in balanced cross-validation (98.2% sensitivity and 98.6% specificity). Moreover, our machine learning approach predicted the presence of lymph node metastasis (LNM) for primary tumours of EC with an accuracy of 80% (90% sensitivity and 69% specificity). Our results demonstrate the capability of MALDI MSI for complementing classic histopathological examination for cancer diagnostic applications.

Indexed as

colorectal cancer (CRC)endometrial cancer (EC)lymph node metastasis (LNM)machine learning (ML)matrix assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI)

Identifiers

PMID34771551
PMCPMC8582378
OpenAlexW3208113211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.